Dose Range-Finding Prenatal Developmental Toxicity Study
Groups of 11 time-mated female rats were administered 0, 300, 650, or 1,000 mg TCPP/kg body weight per day in 0.5% aqueous methylcellulose by gavage from GD 6 to GD 20. Vehicle control (0 mg/kg) animals received aqueous methylcellulose.
Maternal toxicity was observed in the 1,000 mg/kg group as evidenced by seven of eleven dams being either found dead or euthanized moribund. Associated clinical observations in the 1,000 mg/kg group included convulsion, tremors, prone, gasping, hypoactivity, hunched posture, nasal discharge, stained fur, piloerection, salivation, and rooting (pre- and post-dosing) which occurred throughout gestation. One female in the 650 mg/kg group was euthanized moribund on GD 16 with associated clinical observations including cold to touch, hypoactivity, paleness, ataxia, and labored breathing which may have been related to TCPP exposure. All vehicle control and 300 mg/kg animals survived to study termination. There were no TCPP-related effects on maternal body weights, body weight gain, or feed consumption from GD 6 to GD 20. Additionally, there were no significant exposure-related effects on post-implantation loss, fetal body weights, or fetal sex ratio, although there were limited litters available for assessment in the 1,000 mg/kg TCPP group due to maternal toxicity. Finally, there were no significant exposure-related external fetal findings (including examination of the palate).
Prenatal Developmental Toxicity Study
Due to the maternal toxicity observed at 1,000 mg/kg in the dose ranging-finding study, groups of 25 time-mated female rats were administered 0 (n=50), 162.5, 325, or 650 mg TCPP/kg body weight per day in 0.5% aqueous methylcellulose by gavage from GD 6 to GD 20. Vehicle control (0 m/kg) animals received aqueous methylcellulose. Additional animals were added to the vehicle control group to obtain historical control data for both maternal and fetal findings in this strain of rat. In this study, TCPP was well tolerated and there were no exposure-related effects on mortality, maternal body weights, body weight gains, or feed consumption during gestation. Low incidences of clinical observations including nasal discharge, salivation, twitches, ataxia, piloerection, audible respiratory sounds, and hyperactivity were observed in the 650 mg/kg group. Adverse clinical observations were not observed in other groups exposed to TCPP. There were no notable placental or other maternal gross observations at necropsy except for dose-related increases in absolute (9%, 16%, and 26% at 162.5, 325, and 650 mg/kg, respectively) and relative liver weights.
There were no significant effects of TCPP on post-implantation loss, mean fetal body weights, or fetal sex ratio. Likewise, no biologically relevant exposure-related malformations were found in external, visceral, and skeletal fetal exams of groups exposed to TCPP.
Under the conditions of this prenatal study, there was no evidence of developmental toxicity of TCPP in Hsd:Sprague Dawley SD rats administered 162.5, 325, or 650 mg/kg in the absence of overt maternal toxicity.
* Test article name represents the mixture.